Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

58.42%

Threshold

Crossed downwards

Timeline

Published

19.09.2020

Transaction

14.09.2020

Voting rights breakdown

Voting rights acquired4.59%
Voting rights sold58.42%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAK9I00053

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

(regarding certain sales positions)

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open